Akkurt, M. O. Et Al. 2017. Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , vol.30, no.4 , 452-456.

Akkurt, M. O. , Akkurt, I., Altay, M., Coskun, B., Erkaya, S., & SEZİK, M., (2017). Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , vol.30, no.4, 452-456.

Akkurt, Mehmet Et Al. "Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction," JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , vol.30, no.4, 452-456, 2017

Akkurt, Mehmet O. Et Al. "Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction." JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , vol.30, no.4, pp.452-456, 2017

Akkurt, M. O. Et Al. (2017) . "Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction." JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE , vol.30, no.4, pp.452-456.

@article{article, author={Mehmet Ozgur Akkurt Et Al. }, title={Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction}, journal={JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE}, year=2017, pages={452-456} }